Aran Research and Development 1982 Ltd (ARAN) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Aran Research and Development 1982 Ltd stock ILS 78.36, price ILS 43.22, upside +81.3%, quality 82 out of 100. Rating: strongly undervalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range 13.64 ILS – 51.59 ILS · fair‑value band 51.01 ILS – 107.98 ILS · the 43.22 ILS price screens below the 78.36 ILS fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow Aran Research and Development 1982 in your weekly email
Every Wednesday you see whether Aran Research and Development 1982 is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Aran Research & Development (1982) Ltd. engages in the product design and development, and equipment manufacturing businesses for plastics industry in Israel.
Show moreShow less
It operates through Investments in Ventures and Start-Up Companies; Sale of Equipment and Raw Materials; and Product Development, Design, and Manufacturing Services segments.
The company develops various medical devices; water devices and fluid management systems, including pressure and flow regulators, electric and hydraulic valves, air release valves, sprinklers, drippers, taps, water meters, filters, check valves, electronic controllers, and testing devices; and measurement and weighing devices, specialty printers, automatic beverage machines, computerized shopping carts and self-checkout kiosks, industrial and communication devices, and batteries.
It also provides plastic sheets for agriculture, food and industrial packaging, pipes, and other technical products; technical support, training, analysis, after sales, logistics, and other services; and technological consulting, and software and computing personnel placement services.
In addition, the company supplies machines and equipment, such as injection molding machines, robotics and automation, injection molds, hot runner systems, drying dosing and conveying systems, plasticizing screws barrels, ultrasonic welding and cleaning, and raw materials; designs, manufactures, and imports injection molds; and invests in medical start-up companies.
It serves government ministries and public bodies; and the defense, medical and biotechnology, printing, water and agricultural, and consumer products industries.
The company was formerly known as Aran Consulting and Development (1982) Ltd. and changed its name to Aran Research & Development (1982) Ltd. in May 1994. Aran Research & Development (1982) Ltd. was incorporated in 1982 and is based in Caesarea, Israel.
Stock analysis
Aran Research and Development 1982 Ltd (ARAN) currently trades at 43.22 ILS, while our model-based Fair Value estimate is 78.36 ILS, implying the stock looks roughly 45% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 86.00 ILS per share, and 8 of the 13 models we run sit above the 43.22 ILS price.
Bear case: the Asset-Based group reads lowest at 13.73 ILS, and 5 of the 13 models stay below the price. Data coverage for this calculation is high.
Scenario range: 51.01 ILS (bear) to 107.98 ILS (bull), the price of 43.22 ILS sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 82/100 (high quality), in the Industrials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Aran Research and Development 1982 Ltd reported revenue of 263M ILS in FY2025 versus 206M ILS in FY2021, a compound +6.4%/yr. Reported net income was 18.7M ILS in FY2025, compounding +14.3%/yr from FY2021.
Key figures
Market cap 197M ILS Micro · P/E ratio 12.1 · P/S ratio 0.99 · EPS (TTM) 3.57 ILS · Dividend yield 8.1% · Net margin 6.0% · Return on equity 22.6% · Return on assets (EBIT) 6.9% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 16% below its 52-week high and 64% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Industrials peers we cover trades at 8% fair-value upside, at 81%, ARAN screens cheaper than that median.
Fair Value models
Bear51.01 ILSFair Value 78.36 ILSBull107.98 ILS
Price 43.22 ILS · Upside +81.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.0600 ILS per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+20.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.4%
Start year 2020 (pandemic). Over 10 years: +8.7% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+54.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+46.0%
Dividend (yield on the price)8.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.base effect: 46.0% / 18.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.3% → 6%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−22.0%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Israel: IMF forecast 2.1% a year to 2030, 1.7% from 2016 to 2025) that is about −23.6% a year for the price.
Compare Aran Research and Development 1982 Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Conglomerates · 304 stocks
Beats the industry median on 9/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score82 · Top 25%
Fair Value upside+81.3% · Top 25%
Profitability
Return on equity (12 months)22.6% · Top 25%
Return on assets11.9% · Top 25%
Net margin (12 months)8.2% · Above median
Operating margin (12 months)3.9% · Below median
Growth and dividend
Revenue growth (quarter YoY)4.8% · Below median
Dividend yield (12 months)8.1% · Top 25%
Balance sheet
Debt / equity0.08× · Below median
Valuation Multiplesvs Conglomerates median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Aran Research and Development 1982 Ltd Fair Value". https://www.fairvalue-calculator.com/stock/ARAN
Frequently asked questions
Is Aran Research and Development 1982 Ltd (ARAN) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of 78.36 ILS versus a price of 43.22 ILS, about +81% upside (undervalued).
What is the fair value of ARAN?
Our model-based fair value for Aran Research and Development 1982 Ltd is 78.36 ILS (as of Nov 7, 2026), built from audited fundamentals. The current price: 43.22 ILS.
What is the quality score of ARAN?
Aran Research and Development 1982 Ltd has a Quality Score of 82/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Aran Research and Development 1982 Ltd (ARAN)?
Our model-based price target is the fair value of 78.36 ILS (as of Nov 7, 2026) from 13 valuation models. Cautious scenario 51.01 ILS, optimistic scenario 107.98 ILS. It is a calculation from audited fundamentals, not an analyst target.
What is the Aran Research and Development 1982 Ltd stock forecast for 2026?
Our models put fair value at 78.36 ILS, about +81% upside versus a price of 43.22 ILS (undervalued). Cautious scenario 51.01 ILS, optimistic scenario 107.98 ILS. The calculation is refreshed regularly with new filings.
What is the revenue of Aran Research and Development 1982 Ltd (ARAN)?
Aran Research and Development 1982 Ltd reported trailing-twelve-month revenue of about 270M ILS (latest available figure, as of Nov 7, 2026).
Does Aran Research and Development 1982 Ltd pay a dividend?
Aran Research and Development 1982 Ltd currently shows a dividend yield of 8.10% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Aran Research and Development 1982 Ltd (ARAN) and when is the ex-dividend date?
Aran Research and Development 1982 Ltd pays a dividend of 3.50 ILS per share a year, a dividend yield of 8.1%. The last ex-dividend date was Mar 23, 2026. The payout ratio is 98.0% of earnings. Free cash flow covers the dividend 3.60 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Aran Research and Development 1982 Ltd (ARAN)?
For today's price to be fair in a discounted-cash-flow model, Aran Research and Development 1982 Ltd would have to grow free cash flow by -22.0 % per year for five years (discount rate 13.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +22.4 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of ARAN use?
Our models discount Aran Research and Development 1982 Ltd at 13.1 %: a base by market capitalisation (micro), damped by beta 0.43, country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Aran Research and Development 1982 Ltd that is -22.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.1 %) and the same formula as our fair value.
How much growth has Aran Research and Development 1982 Ltd (ARAN) delivered so far?
Over the past 5 years revenue at Aran Research and Development 1982 Ltd grew +22.4 % a year. The price currently implies free-cash-flow growth of -22.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Aran Research and Development 1982 Ltd (ARAN) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into Aran Research and Development 1982 Ltd (-22.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Aran Research and Development 1982 Ltd (ARAN)?
The free-cash-flow yield on the price is 29.02 %: that much free cash flow Aran Research and Development 1982 Ltd produces per unit of market value. When it exceeds the discount rate of our models (13.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Aran Research and Development 1982 Ltd (ARAN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Aran Research and Development 1982 Ltd it is 78.36 ILS per share (as of Nov 7, 2026), against a price of 43.22 ILS. It is the blended result of 13 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Aran Research and Development 1982 Ltd stock overvalued or undervalued in 2026?
As of Nov 7, 2026, ARAN trades below its calculated fair value: price 43.22 ILS, fair value 78.36 ILS, a gap of about +81% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ARAN?
No. The price is what the market pays today (43.22 ILS); the fair value is what the company's own numbers justify (78.36 ILS). For Aran Research and Development 1982 Ltd the two are 35.14 ILS per share apart. That gap is exactly why we show both numbers side by side.
How much is Aran Research and Development 1982 Ltd worth?
The market values Aran Research and Development 1982 Ltd at about 197M ILS (market capitalisation, as of Nov 7, 2026). Per share that is 43.22 ILS; our models calculate a fair value of 78.36 ILS per share.
What do the bullish and bearish scenarios say about ARAN?
Our models span a range for Aran Research and Development 1982 Ltd: cautious scenario 51.01 ILS, base 78.36 ILS, optimistic 107.98 ILS per share (as of Nov 7, 2026, price 43.22 ILS). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ARAN?
Aran Research and Development 1982 Ltd trades at a price-to-earnings ratio of 12.1 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 78.36 ILS is built from several models across several years. Other multiples: P/B 2.1, P/S 1.0, EV/EBITDA 12.5.
How solid is the balance sheet of Aran Research and Development 1982 Ltd (ARAN)?
Balance-sheet figures for Aran Research and Development 1982 Ltd (as of Nov 7, 2026): return on equity 22.6%, debt of 0.08 per unit of equity. They feed the Quality Score of 82/100, which measures business quality independently of the share price.
How far is ARAN from its 52-week high?
Aran Research and Development 1982 Ltd trades at 43.22 ILS, about 16% below its 52-week high of 51.59 ILS and 64% above the low of 26.31 ILS (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 78.36 ILS is for.
Which stocks are comparable to Aran Research and Development 1982 Ltd?
From the same area (Industrials) we also value 3M Company, Honeywell International Inc, Swire Pacific Limited, SGH Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Aran Research and Development 1982 Ltd stock attractive at the current price?
The data as of Nov 7, 2026: price 43.22 ILS, calculated fair value 78.36 ILS (+81%), Quality Score 82/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ARAN calculated?
We run Aran Research and Development 1982 Ltd through 13 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of 78.36 ILS builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Aran Research and Development 1982 Ltd currently trades 45% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Aran Research and Development 1982 Ltd (ARAN)?
The closing price on Nov 6, 2026 was 43.22 ILS. Our model-based fair value is 78.36 ILS, about +81% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Aran Research and Development 1982 Ltd right now?
The rarer combination: high quality (82/100) AND below fair value. That earns a closer look rather than a quick verdict. The price is below even our cautious bear case (51.01 ILS). The market is more pessimistic than our downside scenario. A fairly wide model range (51.01 ILS to 107.98 ILS) leaves room in how you read the outcome.
Where does the earnings growth of Aran Research and Development 1982 Ltd (ARAN) come from?
Earnings per share at Aran Research and Development 1982 Ltd grew +18.5 % a year from 2014 to 2025. Broken into its drivers: revenue per share +9.3 %, EBIT margin +3.5 %, tax rate −0.6 %, residual (interest, one-offs) +5.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Aran Research and Development 1982 Ltd
How large is the market capitalisation of Aran Research and Development 1982 Ltd (ARAN)?
The market capitalisation of Aran Research and Development 1982 Ltd is 197M ILS. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Aran Research and Development 1982 Ltd (ARAN)?
The price-to-sales ratio of Aran Research and Development 1982 Ltd is 0.99 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Aran Research and Development 1982 Ltd (ARAN)?
Earnings per share at Aran Research and Development 1982 Ltd are 3.57 ILS (price ÷ EPS = P/E 12.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Aran Research and Development 1982 Ltd (ARAN)?
The dividend yield of Aran Research and Development 1982 Ltd is 8.1% (payout 98.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Aran Research and Development 1982 Ltd (ARAN)?
The net margin of Aran Research and Development 1982 Ltd is 6.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Aran Research and Development 1982 Ltd (ARAN)?
The return on equity (ROE) of Aran Research and Development 1982 Ltd is 22.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Aran Research and Development 1982 Ltd (ARAN)?
On an EBIT basis the return on assets of Aran Research and Development 1982 Ltd is 6.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Aran Research and Development 1982 Ltd (ARAN)?
The operating margin of Aran Research and Development 1982 Ltd is 3.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Aran Research and Development 1982 Ltd (ARAN)?
Revenue at Aran Research and Development 1982 Ltd is growing +4.8% versus a year earlier (3y avg +15.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Aran Research and Development 1982 Ltd (ARAN)?
Earnings per share at Aran Research and Development 1982 Ltd are growing −40.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Aran Research and Development 1982 Ltd (ARAN) hold?
Aran Research and Development 1982 Ltd holds more cash than debt, 26.6M ILS net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Aran Research and Development 1982 Ltd in the live analysis
One click puts Aran Research and Development 1982 Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 7, 2026